154 related articles for article (PubMed ID: 37086063)
61. [The lymphogenic metastatic pathways of thoracic esophageal carcinoma--their clinical and prognostic significance].
Fietkau R
Strahlenther Onkol; 1994 Dec; 170(12):719-20. PubMed ID: 7817275
[No Abstract] [Full Text] [Related]
62. [Perioperative therapy in esophageal and stomach carcinoma].
Stahl M; Wilke H; Meyer HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
[No Abstract] [Full Text] [Related]
63. Preoperative hyperthermo-chemo-radiotherapy for esophageal carcinoma--analysis of 20 cases.
Sugimachi K; Kai H; Inokuchi K
Jpn J Med; 1985 Feb; 24(1):80-3. PubMed ID: 2582168
[No Abstract] [Full Text] [Related]
64. [A case of esophageal endocrine cell carcinoma with multiple liver metastases that had a complete response to multidisciplinary therapy].
Isshiki H; Satoh S; Yajima H; Itoh A; Yamamoto I; Kawakami K; Naito T; Kubo T; Nakagaki S; Shimizu H; Kaneto H; Kondo T
Nihon Shokakibyo Gakkai Zasshi; 2012 Nov; 109(11):1902-9. PubMed ID: 23132034
[TBL] [Abstract][Full Text] [Related]
65. Oesophageal carcinoma: combined chemo- and radiotherapy.
Dehn TC; Jamieson GG; Gill PG
Br J Surg; 1988 Jun; 75(6):621. PubMed ID: 3395833
[No Abstract] [Full Text] [Related]
66. [Radiotherapy combined with daily low-dose cisplatin for esophageal carcinoma--a pilot study].
Yamada S; Takai Y; Nemoto K; Ogawa Y; Hoshi A; Mitsui H; Sakamoto K
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1689-91. PubMed ID: 8060148
[No Abstract] [Full Text] [Related]
67. Carcinoma of the esophagus: is biology screaming in my deaf ears?
Ajani JA
J Clin Oncol; 2005 Jul; 23(19):4256-8. PubMed ID: 15781878
[No Abstract] [Full Text] [Related]
68. Combined modality therapy for esophageal cancer.
Minsky BD
Semin Oncol; 2003 Aug; 30(4 Suppl 9):46-55. PubMed ID: 12908136
[TBL] [Abstract][Full Text] [Related]
69. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
Leng XF; Daiko H; Han YT; Mao YS
Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
[TBL] [Abstract][Full Text] [Related]
70. [Multimodal treatment of esophageal carcinoma].
Graf D; Vallböhmer D; Knoefel WT; Budach W; Häussinger D
Dtsch Med Wochenschr; 2014 Oct; 139(42):2141-7. PubMed ID: 25289924
[TBL] [Abstract][Full Text] [Related]
71. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
Oncology (Williston Park); 2005 May; 19(6):775-8, 783-4, 788 passim. PubMed ID: 15971452
[No Abstract] [Full Text] [Related]
72. [Salvage surgery after definitive chemoradiation for esophageal carcinoma].
Hokamura N; Tachimori Y
Nihon Geka Gakkai Zasshi; 2008 Jan; 109(1):31-5. PubMed ID: 18320808
[TBL] [Abstract][Full Text] [Related]
73. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.
Luo H; Song H; Mao R; Gao Q; Feng Z; Wang N; Song S; Jiao R; Ni P; Ge H
Cancer Sci; 2019 Nov; 110(11):3464-3475. PubMed ID: 31454136
[TBL] [Abstract][Full Text] [Related]
74. Multimodal therapy for squamous carcinoma of the oesophagus.
McDonnell C; Walsh TN
Br J Surg; 2000 Jan; 87(1):122-3. PubMed ID: 10660350
[No Abstract] [Full Text] [Related]
75. Induction therapy for squamous carcinoma of the thoracic esophagus: the continuing journey.
McLaughlin JS
Ann Thorac Surg; 1994 May; 57(5):1064-5. PubMed ID: 8179365
[No Abstract] [Full Text] [Related]
76. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.
Shaikh T; Thomay A; Ruth K; Cohen SJ; Meyer JE
J Surg Oncol; 2015 Nov; 112(6):629-33. PubMed ID: 26430952
[TBL] [Abstract][Full Text] [Related]
77. [Radiation combined with bleomycin in esophageal carcinoma--a randomized study of 99 patients].
Zhang ZF
Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):372-4. PubMed ID: 6085497
[No Abstract] [Full Text] [Related]
78. Squamous cell carcinoma of the esophagus.
Grover FL
Tex Med; 1984 May; 80(5):38-40. PubMed ID: 6729744
[No Abstract] [Full Text] [Related]
79. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
[No Abstract] [Full Text] [Related]
80. [Surgery and combined modality therapy of esophageal cancer].
Yamada A
Rinsho Hoshasen; 1986 May; 31(5):635-6. PubMed ID: 3747220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
